NOTE
9 — Net Income (Loss) Per Share
The
dilutive effect of outstanding RSUs and other contingently issuable shares is reflected in diluted net income per share by application
of the treasury stock method. The following table sets forth the computation of the Company’s basic and diluted net income (loss)
per share. Amounts for the three months ended March 31, 2024, have been adjusted retrospectively for the Reverse Stock Split.
Schedule of Computation of Basic and Diluted Net Loss Per Share
|
|
2025 |
|
|
2024 |
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2025 |
|
|
2024 |
|
Numerator: |
|
|
|
|
|
|
|
|
Net income (loss) |
|
$ |
458 |
|
|
$ |
(2,906 |
) |
Denominator: |
|
|
|
|
|
|
|
|
Weighted-average shares used in computing net income (loss) per share, basic |
|
|
5,839,764 |
|
|
|
4,438,131 |
|
Net income (loss) per share, basic |
|
$ |
0.08 |
|
|
$ |
(0.65 |
) |
Weighted-average shares used in computing net income (loss) per share, diluted |
|
|
5,868,429 |
|
|
|
4,438,131 |
|
Net income (loss) per share, diluted |
|
$ |
0.08 |
|
|
$ |
(0.65 |
) |
The
potentially dilutive common shares that were excluded from the calculation of diluted net income (loss) per share because their effect
would have been antidilutive are as follows. Share amounts as of March 31, 2024, have been adjusted retroactively for the Reverse Stock
Split.
Summary of Dilutive Common Shares were Excluded from Calculation of Diluted
|
|
2025 |
|
|
2024 |
|
|
|
Three Months Ended |
|
|
|
March 31, |
|
|
|
2025 |
|
|
2024 |
|
Shares subject to options to purchase common stock |
|
|
720,175 |
|
|
|
516,925 |
|
Unvested restricted stock units |
|
|
— |
|
|
|
68,073 |
|
Shares subject to warrants to purchase common stock |
|
|
350,000 |
|
|
|
1 |
|
Total |
|
|
1,070,175 |
|
|
|
584,999 |
|
Additional
shares of the Company’s common stock were issued after March 31, 2025. See Note 11, Subsequent Events.
|